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Mesenchymal stromal cells (MSCs) are able to differentiate into extramesodermal lineages, including neurons. Positive outcomes
were obtained after transplantation of neurally inducedMSCs in laboratory animals after nerve injury, but this is unknown in horses.
Our objectives were to test the ability of equine MSCs to differentiate into cells of neural lineage in vitro, to assess differences in
morphology and lineage-specific protein expression, and to investigate if horse age and cell passage number affected the ability
to achieve differentiation. Bone marrow-derived MSCs were obtained from young and adult horses. Following demonstration of
stemness, MSCs were neurally induced and microscopically assessed at different time points. Results showed that commercially
available nitrogen-coated tissue culture plates supported proliferation and differentiation. Morphological changes were immediate
and all the cells displayed a neural crest-like cell phenotype. Expression of neural progenitor proteins, was assessed via western
blot or immunofluorescence. In our study, MSCs generated from young and middle-aged horses did not show differences in their
ability to undergo differentiation. The effect of cell passage number, however, is inconsistent and further experiments are needed.
Ongoingwork is aimed at transdifferentiating these cells into Schwann cells for transplantation into a peripheral nerve injurymodel
in horses.
1. Introduction
Spinal cord and peripheral nerve injuries in horses occur
after trauma, toxic/metabolic, and infectious diseases. Less
frequently, degenerative and hereditary diseases also pose
a threat. These events trigger an inflammatory cascade of
events that results in poor performance, disability, or death.
Additionally, the impact of peripheral nerve injuries in horses
is reflected by big financial and emotional investments.
Peripheral nerves can be injured by thermal or chemical
injuries, compression, crushing, stretching, or transection
[1, 2]. After injury, the blood-nerve barrier permeability
increases and an inflammatory response is initiated resulting
in proliferation of Schwann cells and activation of local
macrophages that respond to tissue damage [2, 3]. Several of
these cells secrete neurotrophic factors and other substances
that eventually enhance axonal regrowth and remyelination,
depending on the magnitude of the lesion and the chronicity
of it [1, 2, 4–10]. A loss of axonal continuity along with
external nerve structures (neurotmesis, in the Seddon clas-
sification) has the poorest prognosis for recovery [1].
Mesenchymal stromal cells (MSCs) from bone marrow
and adipose tissue have been demonstrated to transdiffer-
entiate into cells of other lineages other than mesodermal
lineages. In vitro research has shown the ability of rodent and
human MSCs to acquire a neural crest-like cell phenotype
after induction with specific culture medium [7–9, 11–13].
Neural protein markers, mainly, vimentin, nestin, 𝛽
3
tubulin,
and glial fibrillary acidic protein (GFAP), were expressed in
these neurally induced cells, although results from different
studies are contradictory and hence inconclusive [10, 13–18].
Interestingly, a novel study involving the evaluation of K+
and Na+ currents in neural crest-like cells revealed that after
chemical induction of rat MSCs, these cells appeared to have
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lost the aforementioned electrophysiological property when
compared to noninduced MSCs; concluding that despite
morphological and molecular changes similar to neural
cells, these chemically induced cells lacked the functional
properties of neurons [14]. Nevertheless, several studies have
shown positive correlation between in vitro and in vivo
results [2, 7, 9, 12, 14, 19–21]. For instance, bone marrow
and adipose-derived undifferentiated MSCs have revealed
positive outcomes when these cells were allogeneically trans-
planted in neurologically injured rats, rabbits, and dogs [2,
9–11, 18–20, 22, 23]. On the other hand, studies in rats
have also shown beneficial responses and regain of nerve
function after transplanting either chemically induced MSCs
into a Schwann cell-like phenotype or pure Schwann cells
obtained from fresh peripheral nerve tissue [9, 11, 23, 24].
It is important to mention, however, that in these studies
cell therapy occurred immediately after nerve or spinal cord
injury.
To our knowledge, there are no reports in the literature
that describe the ability of equine bone marrow-derived
MSCs (eBM-MSCs) to differentiate into cells of neural lineage
or demonstrate the clinical benefits after transplantation
into horses suffering from neuropathies. We have previously
reported that, to improve the clinical outcomes related to
stem cell therapies, it is important to assess the biology and
function of MSCs prior to their application in clinical cases
[25]. In view of our long term goal of using equine MSCs in
neuropathies, the present study was designed as a first step to
evaluate the proliferation and survival of eBM-MSCs in vitro
and their ability to differentiate into neural crest-like cells
after chemical induction. We compared these properties and
assessed changes, if any, in horses (donors) of two age groups.
Additionally, we compared changes in neural differentiation
relative to the passage number of eBM-MSC cultures. We
used the expression profiles of the neural progenitor markers
nestin, vimentin, 𝛽
3
tubulin, and GFAP to investigate these
changes.
2. Materials and Methods
2.1. Animals and Bone Marrow Aspiration. Bone marrow
aspirates were obtained from the sternum of 2 young mixed
breed (range: 1–4 years old) and 4 adult American Quarter
Horse (range: 9–13 years old) mares and 1 young American
Quarter Horse gelding as described previously [26]. All
procedures were carried out as per an approved protocol
by the Institutional Animal Care and Use Committee of the
University of Tennessee, Knoxville, TN. Briefly, horses were
sedated with 0.01-0.02mg/kg of detomidine hydrochloride,
intravenously. A 10 cm band was clipped and surgically
prepared on the ventral aspect of the sternal area. Three mL
of 2% lidocaine hydrochloride were injected subcutaneously
and intramuscularly at the level of the 5th or 6th sternebrae
at the ventral midline, followed by a stab incision with a 15-
blade on the skin, subcutaneous tissue, and musculature. A
Jamshidi needle was inserted perpendicular to the skin until
it reached the periosteum. The needle was then forced into
the sternum and bone marrow from either the 5th or the 6th
sternebrae was obtained by gentle aspiration with a syringe
loaded with 1000 IU/10mL of heparin sulfate.
2.2. Isolation and Expansion ofMSCs. These procedures were
as described earlier [25–27]. Briefly, bone marrow aspirate
was dilutedwith 1X PBS and layered on top of the lymphocyte
separation media, Ficoll. After centrifugation at 200 g for
20min at room temperature, the buffy coat containing
the mononuclear cells (MNCs) was obtained. The MNCs
were resuspended in growth media containing Dulbecco’s
Modified Eagle Medium/Ham’s F-12 [(DMEM-F12), Cellgro,
Manassas, Virginia], 10% fetal bovine serum (FBS), and 1%
penicillin/streptomycin. Roughly 20 × 106 cells were seeded
in 175 cm2 vented tissue culture flasks (Thermo Scientific,
Rochester, NY) and maintained at 37∘C and 5% CO
2
. First
growth medium change was carried out between 5 and 7
days when clusters of colonies were visible under the phase
contrast microscope.When 70–80% confluency was reached,
the cells were harvested with 0.25% trypsin-EDTA for 2min
at 37∘C (passage 1: P1). After centrifugation, the cell pellet
was reconstituted either with the growth medium to start
a new experiment or with freezing media containing 50%
DMEM-F12, 50% FBS, and 5% DMSO for cryopreservation
under liquid nitrogen for future experiments. These steps
were repeated as needed in order to obtain cells from passage
2 to passage 4 (P2 to P4; low passage) and cells from P9 to P12
(high passage) and used in future experiments.
2.3. Demonstration of Stemness on Low Passage Equine
MSCs from 7 Donors
2.3.1. Colony Forming Unit Assay (CFU). Passage 1 of equine
MSCs was seeded at a density of 1 × 106 in 100mm tissue
culture dishes (Thermo Scientific, Rochester, NY) and main-
tained in growth medium for 7 to 10 days until clusters of
colonies were observed.Themediumwas replaced after every
2-3 days. Colonies were fixed with 4% paraformaldehyde
and stained with 0.5% of crystal violet (Sigma-Aldrich, Saint
Louis, MO). After staining, the dishes were allowed to air-dry
and images were acquired with a Fujifilm LAS-4000 imaging
system (GE Healthcare Life Sciences).
2.3.2. MTS Proliferation Assay. Low passage (P2–P4) equine
MSCs were seeded at a density of 2 × 104 per well in a 24-
well tissue culture plate. The medium was replaced every
2-3 days. Cell proliferation was measured at 2, 4, and 7
days after seeding. A CellTiter 96 Aqueous nonradioactive
(MTS) assay (Promega,Madison,WI) was used following the
manufacturer instructions. Briefly,MTS reagent in a 5 : 1 ratio
relative to the media was added to each well and incubated
for 3 h at 37∘C and 5% CO
2
. The absorbance at 490 nm was
measured and data was obtained using Gen5 data analysis
software (Biotek,Winooski, Vermont). Growthmedium only
with no cells was used as a blank to correct the readings for
each of the samples.
2.3.3. Induction of Adipogenic, Osteogenic, and Chondrogenic
Differentiation. Low passage (P2–P4) of equine MSCs was
seeded at a cell density of 2 × 105 cells in 60mm tissue
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culture dishes (BD Falcon, New Jersey) and maintained
at 37∘C and 5% CO
2
in growth medium. When the cells
were roughly 70% confluent, the medium was removed and
was replaced with lineage-specific differentiation media as
described earlier [27]. Briefly, adipogenic differentiation was
induced by the addition of DMEM-F12 medium contain-
ing 15% rabbit serum, 1 𝜇mol/L dexamethasone, 10 𝜇g/mL
recombinant human insulin, 20𝜇mol/L indomethacin, and
0.5mmol/L 3-isobutyl-1-metylxanthine. Osteogenic differen-
tiation was induced by the addition of DMEM-F12 medium
containing 100 nmol/L/mL of dexamethasone, 0.25mmol/L
ascorbic acid, and 10mmol/L 𝛽-glycerophosphate. Chon-
drogenic differentiation was induced by the addition of
DMEM-F12, 100 nmol/L of dexamethasone, 0.25mmol/L
ascorbic acid, and 5 ng/mL transforming growth factor 𝛽
1
.
Medium was replenished every 2-3 days and differentiation
was monitored via microscopic evaluation. Undifferentiated
MSCs maintained in regular growth medium without any
differentiation reagents, for the same number of days, served
as controls. Differentiation was confirmed using lineage-
specific cell staining using previously published methods
[27]. Specifically, adipogenic cells were stained with oil
red-o, osteogenic cells were stained with alizarin red, and
chondrogenic cells were stainedwith alcian blue. Images were
acquired with an electronic camera (Nikon DS-Fi2, Japan)
connected to a Zeiss microscope and evaluated with the NIS-
Elements imaging software (Nikon).
2.4. Neural Crest-Like Cell Differentiation on Low and High
Passage Equine MSCs from Selected Donors. Neural crest-
like cell differentiation was conducted in MSCs from the
7 donors aforementioned. Since we need high numbers of
eBM-MSCs for neural differentiation, to obtain appropriate
protein samples, we selected one young and one middle-aged
donor to conduct the western blot and immunofluorescence
experiments. The donors were chosen based on their rates
of proliferation as demonstrated by the MTS assay described
above.
2.4.1. Cell Culture. Low (P2) and high (P9) of equine
MSCs were seeded at a cell density of 8 to 10 × 106
into either polystyrene or Primaria nitrogen-coated 100mm
tissue culture dishes (Becton Dickinson Labware, Bedford,
MA). Cells were maintained in regular growth medium at
37∘C and 5% CO
2
, for at least 48 h to allow attachment.
Neural differentiation was induced using a combination of
previously described methods [13, 18]. Briefly, the growth
medium was removed and cells were preincubated with
medium containing DMEM-F12, 20% FBS, and 1mM 𝛽-
mercaptoethanol (Sigma-Aldrich) at 37∘C and 5% CO
2
, for
18–24 h. Subsequently, the cells were induced by the addition
of the neural medium containing DMEM-F12, 2% DMSO,
and 200𝜇Mbutylated hydroxyanisole (BHA; Sigma-Aldrich)
and cells were incubated at 37∘C and 5% CO
2
, for 3, 6, 12,
24, or 48 h. Undifferentiated MSCs maintained in regular
growth medium for the same number of hours were used as
corresponding controls. Undifferentiated and differentiated
cells were assayed at the end of each experiment as described
below.
2.4.2. Nuclear/Cytoplasmic Staining. Nuclear/cytoplasmic
fluorescent staining was used to show the neural cell like
morphology of MSCs after neural differentiation. Low and
high passages of equine MSCs were seeded at a density of
1.25 × 106 on Primaria nitrogen-coated 60mm tissue culture
dishes and maintained in regular growth medium at 37∘C
and 5% CO
2
, for at least 48 h to allow attachment.When cells
were 80–90% confluent they were chemically induced for
neural differentiation as described above. Undifferentiated
control MSCs described above were maintained with regular
growth medium. For cytoplasmic staining, neurally induced
and undifferentiated MSCs at 12 h were stained with 5𝜇g of
WGA (wheat germ agglutinin, Alexa Fluor 488 conjugate;
Life Technologies) for 10min, at room temperature. To stain
the nucleus, cells were further washed and stained with 5 𝜇g
of TO-PRO-3 iodide stain (Life Technologies, Grand Island,
NY) for 10min, at room temperature. After washing, the
cells were mounted with SlowFade Gold Antifade Reagent
(Molecular Probes, Grand Island, NY) and images were
obtained with a laser scanning spectral confocal microscope
(Leica TCS SP2; Leica Microsystems©, Wetzlar, Germany),
at 20x and 63x magnification.
2.4.3. Protein Extraction and Western Blot. Total cell lysates
were prepared from undifferentiated and neurally induced
equine MSCs from low and high passages 12 h after dif-
ferentiation using standard protocols. Cells on each dish
were gently washed with HBSS buffer and collected via cell
scraping. To obtain total proteins in each sample, cells were
lysed in 200𝜇L of RIPA buffer (Boston Bioproducts, Ashland,
MA) and sonicated and supernatants were obtained by
centrifugation. Total protein in each sample was quantitated
and concentrations were obtained using modified BCA assay
at 660 nm (Pierce, Thermo Scientific). Equal concentrations
of total proteins from neurally induced and undifferentiated
MSCs were electrophoretically separated in a 10% acrylamide
gel and transferred onto nitrocellulose membranes. The
membranes were blocked with 5% bovine serum albumin
(BSA) and incubated with mouse anti-𝛽
3
tubulin (1 : 1000;
Santa Cruz) and mouse anti-GFAP (5 𝜇g/10mL; 1 : 1000;
BD Pharmingen). HRP goat anti-mouse IgG (1 : 5000; BD
Pharmingen) was used as the secondary antibody. Antigen
detection was performed after exposure to ECL-2 reagent
(Pierce, Thermo Scientific). Beta-actin was used as a loading
control.
2.4.4. Immunofluorescence (IF). Low and high passages of
equine MSCs were seeded at a density of 1.25 × 106 on
Primaria nitrogen-coated 60mm tissue culture dishes and
maintained in growth medium at 37∘C and 5% CO
2
, for at
least 48 h, to allow attachment. When cells were 80–90%
confluent, they were chemically induced for neural differ-
entiation as described above. Undifferentiated MSCs used
as controls were maintained with regular growth medium.
Neurally induced and undifferentiated MSCs were fixed with
4% paraformaldehyde, permeabilized with 0.1% Triton X-100
(Sigma) for 10min, at room temperature, and blocked with
5%normal serum for 30min, at room temperature. Cells were
washed and incubated overnight with 5𝜇g/sample of primary
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antibodies against nestin (BD Pharmingen) and vimentin
(BD Pharmingen), at 4∘C. After washing with HBSS buffer,
cells were incubated with the secondary antibody (Alexa
Fluor 647 donkey anti-mouse IgG at 5𝜇g per sample; BD
Pharmingen) for 20min, at room temperature.The cells were
mounted with SlowFade Gold Antifade with DAPI reagent
(Molecular Probes) and images were obtained with a laser
scanning spectral confocal microscope (Leica TCS SP2; Leica
Microsystems©, Wetzlar, Germany).
2.5. Statistical Analysis. A two-tailed Student’s t-test was
used to compare the average of neural crest-like cells that
adhered to the polystyrene-coated with those to the Primaria
nitrogen-coated tissue culture plates. Similarly, the expres-
sion of nestin and vimentin between cells of P2 and P9
from middle-aged horse and between cells of P2 from young
and middle-aged horse was compared from the IF data. The
expressions of the two proteins were also compared between
undifferentiated and neurally induced MSCs. Differences
were considered statistically significant when 𝑃 < 0.05.
3. Results
3.1. Stemness of Equine MSCs. The stemness of cells from
all equine MSC cultures was assessed solely in low passage
cells. Once the properties of stem cell were demonstrated,
only 1 donor from each group (young and middle-aged) was
selected and the population of MSCs was passaged for neural
experiments.
3.1.1. Morphology. Equine MSC cultures expanded from the
bone marrow harvest adhered to the polystyrene surface
and displayed spindle-shaped fibroblastic morphology. No
morphological change was observed in eBM-MSC cultures
generated from young and middle-aged donors.
3.1.2. Proliferation. Equine MSCs from young (Figure 1:
horses 1–4) and middle-aged donors (Figure 1: horses 5–
7) were capable of proliferation and viability, which were
measured at days 2, 4, and 7. As demonstrated in the figure,
there was a 3- to 6-fold increase in absorbance for all the
donors over a period of 7 days confirming their proliferation
and viability. As expected and previously reported, cellular
proliferation was variable between each horse. Horses that
showed the highest proliferation and thus generated enough
numbers of MSCs in a given period of time were selected for
all neural experiments (donors 2 and 6).
3.1.3. CFU. Equine MSCs of P1of young and middle-
aged horses were capable of growing in clusters over the
polystyrene-coated tissue culture dishes at day 10, suggesting
that the eBM-MSC cultures established represent the MSCs
or the progenitor cells. A representative CFU assay is shown
(Figure 2).
3.1.4. Mesodermal Trilineage Differentiation. Low passage
equineMSCs from both young andmiddle-aged donors were
capable of differentiation into adipogenic, chondrogenic, and
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Figure 1: Measurement of rate of proliferation of eBM-MSCs. MTS
assay was used to compare the rates of proliferation of eBM-MSCs
from 4 young horses (numbers 1–4) and 3 middle-aged horses
(numbers 5–7) over a period of 7 days. Absorbance is the optical
density (OD)measured at 490 nmwith this colorimetric assay. Note
the rapid rate of self-renewal on all animals at day 7. Mean values
of each sample (𝑛 = 7) are presented with the standard deviation
plotted as the error bars.
osteogenic cells under lineage-specific chemical induction
(Figure 3). At day 5, adipogenic cells displayed a typical
pattern of lipid droplet formation which could be stained
with oil red-o. Osteogenic and chondrogenic differentiation
potential was confirmed by alizarin red and alcian blue
staining, respectively, after 10–15 days of chemical induc-
tion. No morphological differences were observed between
horses. Variability existed, however, on the time of reaching
a differentiated phenotype, as judged by specific staining.
Undifferentiated controls remainedwith a spindle fibroblastic
shape at all times and were not positive for lineage-specific
staining. Of importance and in accordance with our pre-
viously published paper [25], osteogenic and chondrogenic
differentiation of MSCs from one middle-age donor (horse
6) consistently occurred earlier than the rest.
All data presented above confirm that equine MSCs
generated from each donor are progenitor cells, and they
satisfy the criteria to be classified as the adult mesenchymal
stromal/progenitor cells.
3.2. Neural Crest-Like Cell Differentiation. After ensuring
selection of MSCs from low passage cells from the previous
experiments, eBM-MSCs were further expanded, passaged,
and tested for neural differentiation.
3.2.1. Neural Crest-Like Cell Morphology. For easy visualiza-
tion, fluorescence microscopy was used to show an intact
nucleus and a “healthy” cytoplasm. TO-PRO-3 stain, the
most sensitive probe for nucleic acid detection, along with
WGA, specific to the cellmembrane, was used to demonstrate
the nucleus and the cytoplasmic structure of the neural-like
Stem Cells International 5
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Figure 2: Colony forming unit assay of eBM-MSCs. Representative image of CFU formed after 10 days of seeding passage 1 eBM-MSCs from
one young (a) and one middle-aged (b) horse. Note the ability of undifferentiated MSCs from both age groups to form CFU.
cells. Low and high passage eBM-MSCs from the selected
young and middle-aged horses were capable of adopting
neural crest-like cellmorphology as early as 3 h after chemical
induction. These morphological characteristics consisted of
elongation of the cell, cell body contraction, and formation
of one or multiple cell processes (Figure 4). After 12 h of
neural differentiation, all the cells displayed neural crest-like
cell morphology. Moreover, these cells appeared to grow in a
cluster in a mesh-like pattern. Undifferentiated controls had
the spindle fibroblastic appearance of a MSC. No differences
were microscopically observed on the phenotypical char-
acteristics of neural crest-like cells of low passage between
young andmiddle-aged horses.When analyzing high passage
cells, subtle morphological differences were detected. The
majority of these cells also displayed the aforementioned
neural crest-like cells characteristics; however, they seemed
to lose their cytoplasmic integrity and some of them appeared
rounded and small. Nuclear and cytoplasmic staining helped
in visual assessment of the morphological characteristics
of these differentiated cells (Figures 5(a) and 5(b)). These
morphological differences were more specific to the passage
numbers; that is, they can be attributed to the process of cell
culture itself, and not to the age of the donor.
Finally, as judged by the numbers of cells adhered to the
2 different types of tissue culture plates, the nitrogen-coated
plates (Primaria) significantly enhanced cell survival and pro-
liferation roughly, 2-fold higher than the polystyrene-coated
plates (𝑃 = 0.0319) after chemical induction (Figure 6).
3.2.2. Expression of Neural Progenitor Proteins. The expres-
sion of vimentin was confirmed by IF (Figures 7 and 8).
Vimentin was expressed by cells of low passage for both
age groups with no significant differences (𝑃 = 0.7653);
cell passage number did not affect vimentin expression on
the middle-age horse (𝑃 = 0.7774), and no difference
on vimentin expression was noted between undifferentiated
MSCs and neurally induced MSCs for young (𝑃 = 0.9660) or
middle-aged (𝑃 = 0.1577) horses.
Immunoblot analysis was carried out to assess the expres-
sion of GFAP and 𝛽
3
tubulin (Figure 9). Differentiated cells
from low passaged cells obtained from middle-aged and
young MSC cultures showed the expression of both the
GFAP and 𝛽
3
tubulin (Figure 9(a)). 𝛽
3
Tubulin was not
expressed in the differentiated cells from high passaged cells
obtained from the young MSC culture. The importance,
if any, is not known at this time. Interestingly, low and
high passaged undifferentiated cells generated from both
donors expressed both proteins, suggesting plasticity ofMSCs
outside of mesodermal lineages (Figure 9(b)).
We were not able to detect nestin expression by western
blot analysis, even when 3 different primary antibodies with
various dilutions (1 : 1000, 1 : 2000) were used. Interestingly,
nestin expression was evident in undifferentiated and neu-
rally differentiated MSCs of low and high passages for both
age groups by IF (Figure 10). Nestin expression on cells of low
passage for both age groups was observed with no significant
differences (𝑃 = 0.7325). Additionally, cell passage number
did not affect significantly the expression of nestin on the
middle-aged horse (𝑃 = 0.3467), and no difference on nestin
expression was noted between undifferentiated MSCs and
neurally induced MSCs for young (𝑃 = 0.9616) or middle-
aged (𝑃 = 0.0830) horses. A perinuclear location of nestin
was evident on undifferentiated and neurally differentiated
MSCs of low passage and on undifferentiated MSCs of high
passage of both age groups (Figure 10).The location of nestin
in neurally differentiated cells of high passage, however, was
inconsistent, with some cells displaying a perinuclear location
and others showing a more diffuse, cytoplasmic expression
(Figure 11). It is possible that cells of high passages undergo
changes that alter the structure of some filamentous proteins
(i.e., nestin).
4. Discussion
Peripheral nerve injuries are a cause of poor performance in
horses. These injuries are difficult to manage and treatment
6 Stem Cells International
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Figure 3: Mesodermal trilineage differentiation assays of eBM-MSCs. Representative images from one young (a) and one middle-aged (b)
horse showing oil red-o (A), alcian blue (B), and alizarin red (C) staining of adipogenesis, chondrogenesis, and osteogenesis, respectively,
after in vitro differentiation. Each undifferentiated control is shown in (b). Scale bar = 100𝜇m.
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Figure 4: Transdifferentiation assay of eBM-MSCs. Representative images from one young (a) and onemiddle-aged (b) horse showing neural
crest-like cells (white arrows) at 12 h after chemical induction. Note the contraction of the cellular body and the appearance of multiple cell
processes. Magnification = 40x.
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Figure 5: Nuclear/cytoplasmic staining of neural-like eBM-MSCs. Representative confocal images of cytoplasmic (WGA) and nuclear (TO-
PRO-3-iodide) fluorescent stains showing the integrity of neural crest-like cells from low passaged eBM-MSCs of one young (a) and one
middle-aged (b) horse and from high passaged eBM-MSC of middle-aged (c) horse. Note the typical fibroblast-like morphology of the
undifferentiated MSCs (d, e, and f). Scale bar = 25𝜇m.
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Figure 6: Nuclear/cytoplasmic staining of neural-like eBM-MSCs on different substrates. Representative confocal images of cytoplasmic
(WGA) and nuclear (TO-PRO-3-iodide) fluorescent stains showing survival of differentiated cells from one middle-aged horse 12 h after
chemical induction, on Primaria, nitrogen-coated (a) and polystyrene-coated (b) tissue culture plates. Note scarce cells on the polystyrene
tissue culture plate. Scale bar = 100 𝜇m.
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Figure 7: Expression of vimentin in undifferentiated and differentiated low passaged eBM-MSCs. Confocal microscopy shows the expression
of vimentin (red) in neural crest-like cells from eBM-MSCs of young and middle-aged horses after 3 h and 12 h of chemical induction. DAPI
was used to stain the nuclei (blue). Respective undifferentiated controls are in the lower panel. Note the diffuse localization of vimentin, which
is expressed in undifferentiated and in neural progenitor cells. Scale bar = 25𝜇m.
mostly relies on physical therapy and anti-inflammatories;
however, the long-term effects are time and personnel con-
suming. The development of nervous system cells is divided
into various stages. After determination of their fate, these
cells migrate to specific locations of the nervous system
and accomplish different functions [18, 28]. Previous studies
have demonstrated that undifferentiated MSCs are able to
express some neural protein markers, leading to the question
whether MSCs are in advance committed to a neural lineage
[29–32]. Moreover, as neural progenitors develop into more
specialized cells, changes in protein markers are also evident
[4, 13, 17, 30, 33].
Adipose-derived and bone marrow-derived MSCs from
humans and rats are able to differentiate into neural lineages
[4, 13, 18, 28, 29, 33–37]. Several reports have described differ-
ent methods of chemical induction for neural differentiation
[13, 30, 33, 37, 38]. Medium containing transretinoic acid
or butylated hydroxyanisole is the most frequently reported.
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Figure 8: Expression of vimentin in undifferentiated and differentiated high passaged eBM-MSCs. Confocalmicroscopy shows the expression
of vimentin (red) in neural crest-like cells from eBM-MSCs of middle-aged horse after 12 h of chemical induction. DAPI was used to stain
the nuclei (blue). Undifferentiated control eBM-MSCs are in the right panel. Note the diffuse localization of vimentin, which is expressed in
undifferentiated and in neural progenitor cells. Scale bar = 25𝜇m.
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Figure 9: Expression of neural progenitor proteins by immunoblot analysis. Western blot analysis shows the expression of the neural
progenitor proteins, 𝛽
3
tubulin and GFAP, in differentiated (a) and undifferentiated (b) eBM-MSCs generated from low and high passaged
cells from middle-aged (lanes 1 and 2, resp.) and young (lanes 3 and 4, resp.) horses. Beta-actin was used as an internal control. 5𝜇g of
protein was loaded per lane. It is interesting to note the expression of neural progenitor proteins in undifferentiated MSCs, suggesting that
the plasticity of equine MSCs may go beyond extramesodermal lineages.
Additionally, coculture systems with MSCs and cells from
nervous tissue have also proven successful for the induction
of neural differentiation of MSCs [29].
We induced trilineage differentiation (osteogenic, chon-
drogenic, and adipogenic) on bone marrow-derived MSCs
from young and middle-aged horses to characterize their
plasticity into mesodermal lineages. We also induced these
cells to differentiate into cells of neural lineage to assess
their plasticity outside of mesodermal lineages. Cells from
all horses were capable of proliferation and underwent dif-
ferentiation into adipogenic, osteogenic, and chondrogenic
lineages.This was consistent with a previous report published
fromour laboratory [25] and, thus, confirmed the stemness of
the cultured MSCs. We cannot ensure cell self-renewal based
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Figure 10: Expression of nestin in undifferentiated and differentiated low passaged eBM-MSCs. Confocal microscopy shows the expression
of nestin (red) in neural crest-like cells (upper panels) and in undifferentiated controls (lower panels) from eBM-MSCs of young andmiddle-
aged horses after 3 h and 12 h of chemical induction. DAPI was used to stain the nuclei (blue). Note the predominant perinuclear localization
of nestin. Scale bar = 25 𝜇m.
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Figure 11: Expression of nestin in undifferentiated and differentiated high passaged eBM-MSCs. Confocal microscopy shows the expression
of nestin (red) in neural crest-like cells (left panel) and in undifferentiated controls (right panel) from eBM-MSCs of middle-aged horse after
12 h of chemical induction. DAPI was used to stain the nuclei (blue). Note that nestin is inconsistently found perinuclearly or diffusely in the
cytoplasm in the differentiated cells. Expression of nestin in the control is perinuclear. Additionally, based on the intensity of the signal, its
expression appears less when compared to cells from the low passage. Scale bar = 25 𝜇m.
on the capability of proliferation of these cells. We, however,
can just hypothesize that equine MSCs may be capable of
self-renewal based on the fact that the cells remained under
undifferentiated state during the experiment and based on
the fact that these cells were also capable of multipotency
when induced with different medium conditions. For the
neural differentiation, fluorescence microscopy revealed that
morphological changes were observed as early as 3 h after
chemical induction in all horses. Using nuclear/cytoplasmic
staining we were able to demonstrate that differentiated
cells acquired a neural crest-like cell morphology in which
retraction of the cell soma and formation of multiple cell
processes were observed. Most importantly, the proliferation
of differentiatedMSCs under the neural media was higher on
the nitrogen-coated plates (Primaria) than on the polystyrene
tissue culture plates, suggesting stabilization of the cell
membrane by providing a positive charge.
By the combination of western blot and IF analyses,
we found that all MSCs, undifferentiated and differenti-
ated, expressed neural progenitormarkers; namely, vimentin,
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nestin, GFAP, and 𝛽
3
tubulin were evident. The expression
of GFAP and 𝛽
3
tubulin in undifferentiated MSCs was
particularly interesting and data are supported by previous
studies in rats and humans, suggesting their capability for
neural lineage differentiation [39, 40]. Nestin has been shown
to be expressed in muscle and neural progenitor cells, as
well as in highly proliferative cells (i.e., following injuries,
high mitotic rate, etc.) [41–43]. In IF data, nestin subjectively
appeared weaker in cells from high passage than cells from
low passage, suggesting the loss of cellular mechanisms for
proliferation and plasticity as the cell ages. We detected a
perinuclear location of nestin in undifferentiated and neural
crest-like cells from P2. In differentiated cells from P9
nestin was expressed perinuclearly but, also extended to the
cytoplasm. This was similar to previous reports [43, 44] and
may suggest posttranslational modifications of nestin [42–
44], the analysis of which was beyond the scope of our study.
Similarly, the effect of cell passage number on the expression
of these markers also suggested modifications or structural
changes as the cells age, but further studies are needed to
confirm this.
Our study mainly relies on morphological changes and
neural marker protein expression to describe the events
occurring during neural differentiation of eBM-MSCs. Our
results agree with previous in vitro studies performed in bone
marrow-derived MSCs from rat, human, and dogs in which
eBM-MSCs are chemically induced into cells that display
morphologic, genetic, and protein characteristics of neural
progenitors. To our knowledge, this is the first report describ-
ing the plasticity, morphological characteristics, and protein
expression changes of eBM-MSCs into cells of neural lineage
after chemical induction.We have not only demonstrated the
in vitro differentiation patterns but also validated the cross-
reactivity of human neural-specific antibodies with equine
protein samples. Further studies are, however, warranted for
investigating the functionality of these horse cells in vivo.
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